https://doi.org/10.4081/aiua.2024.12382

Factors associated to hemoglobin decrease after percutaneous nephrolithotomy: a retrospective study

Vol. 96 No. 2 (2024)
Submitted: February 13, 2024
Accepted: February 24, 2024
Published: May 20, 2024
Bleeding, hemoglobin, stone, percutaneous nephrolithotomy (PCNL)
Abstract Views: 559
PDF: 235
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Syarif Syarif
syarifbakri@hotmail.com
https://orcid.org/0000-0001-7382-4180
Division of Urology, Department of Surgery, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
Abdul Azis
Division of Urology, Department of Surgery, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
Saidah Rahmat A.
Faculty of Medicine, Muhammadiyah Malang University, Malang, Indonesia.
Ahmad Taufik Fadillah Zainal
Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
Ade Nusraya
Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.

Objective: This study aims to determine the preoperative and perioperative risk parameters associated with a decrease in hemoglobin (Hb) in patients undergoing percutaneous nephrolithotomy (PCNL).
Methods: We collected prospective data of consecutive patients who underwent PCNL from January 2018 to December 2022. The median decrease in post-operative hemoglobin levels compared to pre-operative was found to be 1.5 g/dl. This value was the cut-off value that divided the sample into two groups. Group 1 has a decrease in Hb levels that is higher or equal to the cutoff, group 2 has a decrease in Hb levels that is lower than the cut-off. All preoperative, stone characteristics and perioperative factors were recorded.
Results: A total of 273 patients were included in the study, 141 in Group 1 and 132 in Group 2. The mean age of Group 1 was significantly higher (55.48 ± 8.73 vs 45.9 ± 10.75 years, p < 0.05). The mean bleeding of Group 1 was significantly higher (285.85 ± 113.68 vs 135 ± 77.54 ml, p < 0.05). There was a significant difference in mean operation time between groups (86.35 ± 32.05 vs 64.89 ± 27.83 min, p < 0.05). Multivariate analysis showed that the variables age, comorbid diabetes mellitus, intraoperative bleeding amount, and operation time had a significant relationship with Hb reduction in patients undergoing PCNL (p < 0.05).
Conclusions: Older age, comorbid diabetes mellitus, large amounts of intraoperative bleeding, and longer operating time are factors associated with PCNL-related postoperative hemoglobin decrease.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Yu J, Park HK, Kwon HJ, et al. Risk factors for acute kidney injury after percutaneous nephrolithotomy: Implications of intraoperative hypotension. Medicine (Baltimore). 2018; 97:e11580. DOI: https://doi.org/10.1097/MD.0000000000011580
Batagello CA, Vicentini FC, Monga M, et al. Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: a randomised, double-blinded, placebo-controlled trial. BJU Int. 2022; 129:35-47. DOI: https://doi.org/10.1111/bju.15378
de la Rosette JJMCH, Opondo D, Daels FPJ, et al. Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol. 2012; 62:246-55. DOI: https://doi.org/10.1016/j.eururo.2012.03.055
Sharma A, Parab S, Goyal G, et al. Comparison of single-step renal dilatation and serial renal dilatation in percutaneous nephrolithotomy: A retrospective case-control study. Urol Ann. 2021; 13:374-7. DOI: https://doi.org/10.4103/UA.UA_118_20
Türk C, Petrík A, Sarica K, et al. EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol. 2016; 69:475-82. DOI: https://doi.org/10.1016/j.eururo.2015.07.041
Skolarikos A, Gross AJ, Krebs A, et al. Outcomes of Flexible Ureterorenoscopy for Solitary Renal Stones in the CROES URS Global Study. J Urol. 2015; 194:137-43. DOI: https://doi.org/10.1016/j.juro.2015.01.112
Alken P, Hutschenreiter G, Günther R. Percutaneous kidney stone removal. Eur Urol. 1982; 8:304-11. DOI: https://doi.org/10.1159/000473540
Segura JW, Patterson DE, LeRoy AJ, et al. Percutaneous removal of kidney stones: review of 1,000 cases. J Urol. 1985; 134:1077-81. DOI: https://doi.org/10.1016/S0022-5347(17)47633-6
Tiselius HG, Ackermann D, Alken P, et al. Guidelines on urolithiasis. Eur Urol. 2001; 40:362-71. DOI: https://doi.org/10.1159/000049803
Matlaga BR, Kim SC, Lingeman JE. Improving outcomes of percutaneous nephrolithotomy: Access. EAU Update Series. 2005; 3:37-43. DOI: https://doi.org/10.1016/j.euus.2004.11.002
Davidoff R, Bellman GC. Influence of technique of percutaneous tract creation on incidence of renal hemorrhage. J Urol. 1997; 157:1229-31. DOI: https://doi.org/10.1016/S0022-5347(01)64931-0
Michel MS, Trojan L, Rassweiler JJ. Complications in percutaneous nephrolithotomy. Eur Urol. 2007; 51:899-906. DOI: https://doi.org/10.1016/j.eururo.2006.10.020
Stoller ML, Wolf JS, St Lezin MA. Estimated blood loss and transfusion rates associated with percutaneous nephrolithotomy. J Urol. 1994; 152:1977-81. DOI: https://doi.org/10.1016/S0022-5347(17)32283-8
Eksi M, Ozlu DN, Kargi T, et al. Pre-Operative Parameters Predicting Hemoglobin Decline Related to Percutaneous Nephrolithotomy. Sisli Etfal Hastan Tip Bul. 2022; 56:70-6. DOI: https://doi.org/10.14744/SEMB.2021.21284
Taylor E, Miller J, Chi T, Stoller ML. Complications associated with percutaneous nephrolithotomy. Transl Androl Urol. 2012; 1:223-8.
Tefekli A, Ali Karadag M, Tepeler K, et al. Classification of percutaneous nephrolithotomy complications using the modified clavien grading system: looking for a standard. Eur Urol. 2008; 53:184-90. DOI: https://doi.org/10.1016/j.eururo.2007.06.049
Du N, Ma JQ, Luo JJ, et al. The Efficacy and Safety of Transcatheter Arterial Embolization to Treat Renal Hemorrhage after Percutaneous Nephrolithotomy. Biomed Res Int. 2019; 2019:6265183. DOI: https://doi.org/10.1155/2019/6265183
Kukreja R, Desai M, Patel S, et al. Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol. 2004; 18:715-22. DOI: https://doi.org/10.1089/0892779042360599
Syahputra FA, Birowo P, Rasyid N, et al. Blood loss predictive factors and transfusion practice during percutaneous nephrolithotomy of kidney stones: a prospective study. F1000Res. 2016; 5:1550. DOI: https://doi.org/10.12688/f1000research.8993.1
Wilson R, et al. Predictors of blood loss during percutaneous nephrolithotomy. Journal of Endourology. 2015; 29:402-6.
Chen Q, et al. Risk factors for bleeding during percutaneous nephrolithotomy: A retrospective study. J Endourol. 2017; 31:581-6.
Lee C, et al. Predictors of postoperative hemoglobin decrease and blood transfusion in percutaneous nephrolithotomy. World J Urol. 2018; 36:263-9.
Kumar A, et al. Predictors of blood transfusion in percutaneous nephrolithotomy: A prospective study. J Urol. 124:153-9.

How to Cite

Syarif, S., Azis, A., Rahmat A., S., Fadillah Zainal, A. T., & Nusraya, A. (2024). Factors associated to hemoglobin decrease after percutaneous nephrolithotomy: a retrospective study. Archivio Italiano Di Urologia E Andrologia, 96(2). https://doi.org/10.4081/aiua.2024.12382
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.